Intuitive Surgical Company Profile (NASDAQ:ISRG)

About Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical logoIntuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ISRG
  • CUSIP: 46120E60
  • Web:
  • Market Cap: $33.54 billion
  • Outstanding Shares: 36,840,000
Average Prices:
  • 50 Day Moving Avg: $833.96
  • 200 Day Moving Avg: $724.51
  • 52 Week Range: $610.71 - $914.76
  • Trailing P/E Ratio: 45.89
  • Foreward P/E Ratio: 33.37
  • P/E Growth: 3.46
Sales & Book Value:
  • Annual Revenue: $2.78 billion
  • Price / Sales: 12.06
  • Book Value: $112.16 per share
  • Price / Book: 8.12
  • EBIDTA: $1.08 billion
  • Net Margins: 27.21%
  • Return on Equity: 14.24%
  • Return on Assets: 12.74%
  • Current Ratio: 5.45%
  • Quick Ratio: 5.14%
  • Average Volume: 328,747 shs.
  • Beta: 0.55
  • Short Ratio: 8.54

Frequently Asked Questions for Intuitive Surgical (NASDAQ:ISRG)

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) announced its quarterly earnings results on Tuesday, April, 18th. The company reported $5.09 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $3.97 by $1.12. The firm had revenue of $674.20 million for the quarter, compared to the consensus estimate of $664.72 million. Intuitive Surgical had a net margin of 27.21% and a return on equity of 14.24%. The firm's quarterly revenue was up 13.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.42 earnings per share. View Intuitive Surgical's Earnings History.

When will Intuitive Surgical make its next earnings announcement?

Intuitive Surgical is scheduled to release their next quarterly earnings announcement on Monday, July, 17th 2017. View Earnings Estimates for Intuitive Surgical.

Where is Intuitive Surgical's stock going? Where will Intuitive Surgical's stock price be in 2017?

18 brokerages have issued 12-month price objectives for Intuitive Surgical's stock. Their predictions range from $600.00 to $1,000.00. On average, they anticipate Intuitive Surgical's stock price to reach $831.47 in the next year. View Analyst Ratings for Intuitive Surgical.

What are analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:

  • 1. According to Zacks Investment Research, "Intuitive Surgical reported stellar first-quarter 2017 results, crushing the Zacks Consensus Estimate on both the counts on the growing adoption of the da Vinci system (a surgical platform) among physicians and overall growth in global procedures. The company’s CE Mark approval for da Vinci X in the recent past is a key catalyst. A positive outlook for the coming quarters raises our confidence in the stock. Over the past three months, Intuitive Surgical outperformed the broader industry in terms of price performance. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia. However, the da Vinci Surgical System has a long sale and purchase order cycle which might act against the company." (5/24/2017)
  • 2. Canaccord Genuity analysts commented, "Our checks at the SAGES conference in Houston this week reaffirmed our near-term bullishness about the firm's fundamentals. A year ago coming out of this important trade show, we opined that a robotics revolution was underway in general surgery;our checks at SAGES 2017 suggest the revolution continues ' especially in hernia repair. Given the large opportunity open to robotic surgery ' nearly 1M annual hernia procedures in the U.S. of which nearly 70% are currently performed via an invasive, open surgery ' we discerned escalating enthusiasm from robotic surgeons. In sum, we think ISRG is positioned well to deliver procedure volume growth at or above its current guidance, which calls for 9-12% growth in 2017. On the competitive front, Medtronic looks to be at least a few years out, but seems to be ISRG's most imminent challenger. At an analyst meeting during SAGES yesterday, Medtronic updated its projections for entry into the surgical robotics arena, targeting initial market entry into a few small countries in Europe before the end of F2018 (April '18). Further, Medtronic expects FDA approval, as well as market expansion into larger European markets, during its F2019, with material revenue contributions expected over that timeframe. Meanwhile, we think ISRG (the company and the stock) still has room to run. We maintain our BUY rating and $800 price target." (3/24/2017)

Who are some of Intuitive Surgical's key competitors?

Who are Intuitive Surgical's key executives?

Intuitive Surgical's management team includes the folowing people:

  • Lonnie M. Smith, Independent Chairman of the Board
  • Gary S. Guthart Ph.D., President, Chief Executive Officer, Director
  • Marshall L. Mohr, Chief Financial Officer, Senior Vice President
  • Salvatore J. Brogna, Executive Vice President - Product Operations
  • David J. Rosa, Executive Vice President, Chief Commercial Officer
  • Mark J. Meltzer, Senior Vice President, Chief Compliance Officer, General Counsel
  • Myriam J. Curet M.D., Senior Vice President, Chief Medical Officer
  • Jamie E. Samath, Vice President, Corporate Controller, and Principal Accounting Officer
  • Alan J. Levy Ph.D., Lead Independent Director
  • Craig H. Barratt Ph.D., Independent Director

Who owns Intuitive Surgical stock?

Intuitive Surgical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.73%), Vanguard Group Inc. (6.80%), FMR LLC (6.18%), State Street Corp (4.40%), Bank of New York Mellon Corp (4.38%) and Baillie Gifford & Co. (4.20%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.

Who sold Intuitive Surgical stock? Who is selling Intuitive Surgical stock?

Intuitive Surgical's stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Manning & Napier Advisors LLC, Morgan Stanley, TIAA CREF Investment Management LLC, Columbus Circle Investors, JPMorgan Chase & Co., Wells Fargo & Company MN and Bank of New York Mellon Corp. Company insiders that have sold Intuitive Surgical stock in the last year include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.

Who bought Intuitive Surgical stock? Who is buying Intuitive Surgical stock?

Intuitive Surgical's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Edgewood Management LLC, Waddell & Reed Financial Inc., FMR LLC, Gilder Gagnon Howe & Co. LLC, Wellington Management Group LLP, Pictet Asset Management Ltd. and Swiss National Bank. View Insider Buying and Selling for Intuitive Surgical.

How do I buy Intuitive Surgical stock?

Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intuitive Surgical's stock price today?

One share of Intuitive Surgical stock can currently be purchased for approximately $910.36.

MarketBeat Community Rating for Intuitive Surgical (NASDAQ ISRG)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  409 (Vote Outperform)
Underperform Votes:  343 (Vote Underperform)
Total Votes:  752
MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Intuitive Surgical (NASDAQ:ISRG) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 13 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $831.47 (8.67% downside)

Analysts' Ratings History for Intuitive Surgical (NASDAQ:ISRG)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/25/2017Wells Fargo & CoReiterated RatingOutperform$1,000.00LowView Rating Details
5/22/2017Morgan StanleySet Price TargetOverweight$840.00 -> $950.00LowView Rating Details
5/16/2017Goldman Sachs Group IncInitiated CoverageBuy -> Buy$1,000.00MediumView Rating Details
4/25/2017Jefferies Group LLCReiterated RatingBuy$675.00LowView Rating Details
4/24/2017WedbushBoost Price TargetOutperform$835.00 -> $875.00LowView Rating Details
4/22/2017Leerink SwannReiterated RatingOutperform$840.00 -> $850.00LowView Rating Details
4/22/2017Citigroup IncReiterated RatingBuy$820.00 -> $917.00LowView Rating Details
4/20/2017BTIG ResearchReiterated RatingHoldLowView Rating Details
4/19/2017Stifel NicolausBoost Price TargetBuy$800.00 -> $850.00LowView Rating Details
4/19/2017Evercore ISIBoost Price TargetIn-Line$750.00 -> $785.00LowView Rating Details
4/19/2017Canaccord GenuityReiterated RatingBuy$800.00 -> $870.00MediumView Rating Details
4/19/2017Barclays PLCReiterated RatingBuy$800.00 -> $830.00HighView Rating Details
4/17/2017Royal Bank of CanadaBoost Price TargetSector Perform -> Sector Perform$720.00 -> $770.00MediumView Rating Details
2/14/2017Bank of America CorpSet Price TargetBuy$770.00 -> $800.00N/AView Rating Details
9/20/2016JPMorgan Chase & Co.Reiterated RatingBuyN/AView Rating Details
8/26/2016Raymond James Financial, Inc.Initiated CoverageOutperformN/AView Rating Details
7/21/2016Northland SecuritiesDowngradeMarket Perform -> Under Perform$600.00N/AView Rating Details
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$610.00 -> $700.00N/AView Rating Details
4/14/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
1/22/2016William BlairReiterated RatingBuyN/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Intuitive Surgical (NASDAQ:ISRG)
Earnings by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Earnings History by Quarter for Intuitive Surgical (NASDAQ:ISRG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/18/2017Q1 17$3.97$5.09$664.72 million$674.20 millionViewN/AView Earnings Details
1/24/2017Q416$5.99$6.09$739.65 million$757.00 millionViewN/AView Earnings Details
10/18/2016Q3$5.13$6.19$650.49 million$682.90 millionViewListenView Earnings Details
7/19/2016Q216$4.97$5.62$640.69 million$670.00 millionViewListenView Earnings Details
4/19/2016Q1$4.33$4.42$593.08 million$594.50 millionViewListenView Earnings Details
1/21/2016Q4$5.04$5.89$655.32 million$676.50 millionViewListenView Earnings Details
10/20/2015Q3$4.23$5.24$580.37 million$590.00 millionViewListenView Earnings Details
7/21/2015Q2$3.98$4.57$566.86 million$586.10 millionViewListenView Earnings Details
4/21/2015Q1$2.85$3.57$535.10 million$532.10 millionViewListenView Earnings Details
1/22/2015Q4$3.43$4.18$599.17 million$604.70 millionViewListenView Earnings Details
10/21/2014Q314$2.68$3.92$515.44 million$550.00 millionViewListenView Earnings Details
7/22/2014Q214$2.76$2.77$502.23 million$512.00 millionViewListenView Earnings Details
4/22/2014Q114$3.34$2.67$507.04 million$464.70 millionViewListenView Earnings Details
1/23/2014Q413$3.81$4.28$576.00 million$576.20 millionViewListenView Earnings Details
10/17/2013Q313$3.40$3.99$525.47 million$499.00 millionViewListenView Earnings Details
7/18/2013Q2 2013$4.04$3.90$594.58 million$578.50 millionViewListenView Earnings Details
4/18/2013Q1 2013$4.02$4.56$583.59 million$611.40 millionViewListenView Earnings Details
1/22/2013Q4 2012$4.02$4.25$584.36 million$609.30 millionViewListenView Earnings Details
10/16/2012$3.51$4.46ViewN/AView Earnings Details
7/19/2012$3.57$3.75ViewN/AView Earnings Details
4/17/2012$3.15$3.50ViewN/AView Earnings Details
1/19/2012$3.35$3.75ViewN/AView Earnings Details
10/18/2011$2.81$3.05ViewN/AView Earnings Details
7/19/2011$2.71$2.91ViewN/AView Earnings Details
4/19/2011$2.49$2.59ViewN/AView Earnings Details
1/20/2011$2.25$3.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Intuitive Surgical (NASDAQ:ISRG)
2017 EPS Consensus Estimate: $19.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$3.96$3.96$3.96
Q2 20171$4.55$4.55$4.55
Q3 20171$4.89$4.89$4.89
Q4 20171$5.68$5.68$5.68
(Data provided by Zacks Investment Research)


Dividend History for Intuitive Surgical (NASDAQ:ISRG)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Intuitive Surgical (NASDAQ:ISRG)
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 91.16%
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2017Jamie SamathVPSell48$850.00$40,800.00View SEC Filing  
5/2/2017Curet MyriamSVPSell3,385$837.21$2,833,955.85View SEC Filing  
4/27/2017Marshall MohrCFOSell8,950$835.89$7,481,215.50View SEC Filing  
4/25/2017Jamie SamathVPSell626$825.00$516,450.00View SEC Filing  
4/24/2017Alan J LevyDirectorSell1,386$813.15$1,127,025.90View SEC Filing  
4/21/2017David J. RosaEVPSell5,000$810.52$4,052,600.00View SEC Filing  
4/21/2017Gary S GuthartCEOSell18,775$810.33$15,213,945.75View SEC Filing  
4/21/2017Jamie SamathVPSell490$811.67$397,718.30View SEC Filing  
4/21/2017Lonnie M SmithDirectorSell3,000$810.12$2,430,360.00View SEC Filing  
3/15/2017Amal M JohnsonDirectorSell1,000$750.00$750,000.00View SEC Filing  
3/15/2017David J RosaEVPSell5,000$750.00$3,750,000.00View SEC Filing  
3/15/2017Jamie SamathVPSell4,268$750.00$3,201,000.00View SEC Filing  
3/15/2017Marshall MohrCFOSell4,250$750.00$3,187,500.00View SEC Filing  
3/1/2017Salvatore BrognaEVPSell6,628$736.80$4,883,510.40View SEC Filing  
2/24/2017Curet MyriamSVPSell222$729.80$162,015.60View SEC Filing  
2/21/2017Mark J MeltzerSVPSell8,750$724.82$6,342,175.00View SEC Filing  
2/7/2017Colin MoralesSVPSell1,000$703.99$703,990.00View SEC Filing  
2/2/2017Marshall MohrCFOSell2,000$700.00$1,400,000.00View SEC Filing  
1/27/2017Lonnie M SmithDirectorSell1,000$684.38$684,380.00View SEC Filing  
12/13/2016David J RosaEVPSell7,200$650.00$4,680,000.00View SEC Filing  
12/13/2016Lonnie M SmithDirectorSell1,000$650.00$650,000.00View SEC Filing  
11/17/2016Lonnie M SmithDirectorSell275$646.50$177,787.50View SEC Filing  
11/7/2016Gary S GuthartCEOSell13,515$680.68$9,199,390.20View SEC Filing  
8/22/2016Mark J MeltzerSVPSell3,000$688.33$2,064,990.00View SEC Filing  
8/4/2016Alan J LevyDirectorSell3,188$694.11$2,212,822.68View SEC Filing  
8/1/2016Gary S GuthartCEOSell13,400$698.00$9,353,200.00View SEC Filing  
7/27/2016Curet MyriamSVPSell4,250$684.39$2,908,657.50View SEC Filing  
7/27/2016Marshall MohrCFOSell5,000$684.09$3,420,450.00View SEC Filing  
6/2/2016Salvatore BrognaEVPSell600$630.96$378,576.00View SEC Filing  
6/1/2016Salvatore BrognaEVPSell20,406$632.66$12,910,059.96View SEC Filing  
5/17/2016Curet MyriamSVPSell530$629.36$333,560.80View SEC Filing  
5/17/2016Lonnie M SmithDirectorSell2,000$627.23$1,254,460.00View SEC Filing  
5/3/2016George Stalk JrDirectorSell7,644$618.70$4,729,342.80View SEC Filing  
5/2/2016Marshall MohrCFOSell5,000$631.63$3,158,150.00View SEC Filing  
4/27/2016Mark J MeltzerSVPSell16,625$631.52$10,499,020.00View SEC Filing  
4/26/2016Alan J LevyDirectorSell542$631.72$342,392.24View SEC Filing  
4/25/2016Amal M JohnsonDirectorSell2,500$640.00$1,600,000.00View SEC Filing  
4/22/2016Curet MyriamSVPSell8,173$637.75$5,212,330.75View SEC Filing  
4/22/2016Eric H HalvorsonDirectorSell5,688$639.21$3,635,826.48View SEC Filing  
3/14/2016Eric H HalvorsonDirectorSell4,438$593.16$2,632,444.08View SEC Filing  
3/14/2016Mark J MeltzerSVPSell12,500$589.00$7,362,500.00View SEC Filing  
3/11/2016Curet MyriamSVPSell2,000$582.50$1,165,000.00View SEC Filing  
3/11/2016Jamie SamathVPSell8,026$575.95$4,622,574.70View SEC Filing  
3/10/2016Alan J LevyDirectorSell5,000$569.14$2,845,700.00View SEC Filing  
3/7/2016Colin MoralesSVPSell2,500$575.00$1,437,500.00View SEC Filing  
3/4/2016Colin MoralesSVPSell884$571.49$505,197.16View SEC Filing  
3/3/2016Marshall MohrCFOSell2,500$575.00$1,437,500.00View SEC Filing  
3/2/2016Salvatore BrognaEVPSell1,882$567.37$1,067,790.34View SEC Filing  
2/19/2016Colin MoralesSVPSell5,530$542.83$3,001,849.90View SEC Filing  
2/4/2016Curet MyriamSVPSell2,000$551.00$1,102,000.00View SEC Filing  
2/4/2016Marshall MohrCFOSell2,500$550.00$1,375,000.00View SEC Filing  
1/29/2016Mark J. MeltzerSVPSell4,125$527.59$2,176,308.75View SEC Filing  
12/14/2015Salvatore BrognaEVPSell2,734$530.00$1,449,020.00View SEC Filing  
11/20/2015Mark J. MeltzerSVPSell1,625$515.00$836,875.00View SEC Filing  
10/26/2015Mark J. MeltzerSVPSell2,500$498.37$1,245,925.00View SEC Filing  
10/23/2015Lonnie M. SmithDirectorSell10,328$500.00$5,164,000.00View SEC Filing  
9/1/2015Salvatore BrognaEVPSell374$501.99$187,744.26View SEC Filing  
8/18/2015George Stalk JrDirectorSell4,726$532.03$2,514,373.78View SEC Filing  
7/27/2015Gary S GuthartCEOSell17,255$541.98$9,351,864.90View SEC Filing  
7/27/2015Mark J MeltzerSVPSell4,750$542.03$2,574,642.50View SEC Filing  
7/24/2015David J RosaEVPSell2,800$550.20$1,540,560.00View SEC Filing  
7/24/2015Jamie SamathVPSell5,000$550.00$2,750,000.00View SEC Filing  
7/24/2015Lonnie M SmithDirectorSell20,000$544.62$10,892,400.00View SEC Filing  
6/9/2015Alan J LevyDirectorSell417$495.41$206,585.97View SEC Filing  
6/8/2015Gary S GuthartCEOSell17,840$492.16$8,780,134.40View SEC Filing  
5/29/2015Lonnie M SmithDirectorSell2,000$488.68$977,360.00View SEC Filing  
5/27/2015Curet MyriamSVPSell1,000$489.35$489,350.00View SEC Filing  
5/18/2015Colin MoralesSVPSell13,824$503.29$6,957,480.96View SEC Filing  
4/28/2015Curet MyriamSVPSell261$504.54$131,684.94View SEC Filing  
4/27/2015Jerome J McnamaraEVPSell15,000$504.06$7,560,900.00View SEC Filing  
4/27/2015Marshall MohrCFOSell10,000$504.08$5,040,800.00View SEC Filing  
4/24/2015Lonnie M SmithDirectorSell20,000$508.03$10,160,600.00View SEC Filing  
3/2/2015Salvatore BrognaSVPSell1,375$500.98$688,847.50View SEC Filing  
2/6/2015Mark J RubashDirectorSell5,000$520.00$2,600,000.00View SEC Filing  
1/27/2015Jerome J McnamaraEVPSell15,000$511.32$7,669,800.00View SEC Filing  
1/27/2015Lonnie M SmithDirectorSell20,000$511.31$10,226,200.00View SEC Filing  
1/27/2015Marshall MohrCFOSell5,000$511.14$2,555,700.00View SEC Filing  
12/8/2014Lonnie M SmithDirectorSell1,700$511.24$869,108.00View SEC Filing  
12/1/2014Salvatore BrognaSVPSell1,375$515.87$709,321.25View SEC Filing  
11/24/2014Colin MoralesSVPSell9,565$520.82$4,981,643.30View SEC Filing  
10/31/2014Marshall MohrCFOSell7,500$500.00$3,750,000.00View SEC Filing  
10/30/2014Floyd D Md LoopDirectorSell2,125$488.95$1,039,018.75View SEC Filing  
10/27/2014Floyd D Md LoopDirectorSell15,209$475.71$7,235,073.39View SEC Filing  
10/27/2014Jerome J McnamaraEVPSell15,000$473.76$7,106,400.00View SEC Filing  
10/27/2014Marshall MohrCFOSell2,500$473.50$1,183,750.00View SEC Filing  
9/2/2014Salvatore BrognaSVPSell12,626$472.06$5,960,229.56View SEC Filing  
8/26/2014Colin MoralesSVPSell4,105$478.66$1,964,899.30View SEC Filing  
7/28/2014Jerome J McnamaraEVPSell9,167$465.59$4,268,063.53View SEC Filing  
7/25/2014Colin MoralesSVPSell2,000$461.99$923,980.00View SEC Filing  
2/27/2014Colin MoralesSVPSell1,000$445.00$445,000.00View SEC Filing  
12/3/2012Lonnie M SmithChairmanSell1,000$525.98$525,980.00View SEC Filing  
9/4/2012Salvatore BrognaSVPSell1,250$490.25$612,812.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Intuitive Surgical (NASDAQ:ISRG)
Latest Headlines for Intuitive Surgical (NASDAQ:ISRG)
DateHeadline logoIntuitive Surgical, Inc. (ISRG) Earns Outperform Rating from Wells Fargo & Co - May 27 at 6:22 PM logoIntuitive: A True Pioneer - Intuitive Surgical, Inc. (NASDAQ:ISRG ... - Seeking Alpha - May 27 at 4:48 AM logoCracking the $1K club - May 26 at 6:45 PM logoZacks Investment Research Upgrades Intuitive Surgical, Inc. (ISRG) to Buy - May 24 at 10:28 AM logoIntuitive Surgical Stock Just Hit an All-Time High: Buy, Sell, or Hold? - May 24 at 8:19 AM logoIntuitive Surgical Inc. (ISRG) Rose To Another New High For The Year - May 23 at 11:09 AM logoIntuitive Surgical's Sp Ushers In The Next Phase Of Growth Story - May 22 at 5:28 PM logoIntuitive Surgical's Sp Ushers In The Next Phase Of Growth Story - May 22 at 5:28 PM logoIntuitive Surgical at 52-Week High: What's Driving the Stock? - May 22 at 5:28 PM logoIntuitive Surgical, Inc. (ISRG) Earns "Overweight" Rating from Morgan Stanley - May 22 at 12:44 PM logoWhy Is Intuitive Surgical (ISRG) Up 5.4% Since the Last Earnings Report? - Nasdaq - May 19 at 10:45 PM logoIntuitive Surgical: A Cut Above - May 19 at 10:31 AM logoWhy Is Intuitive Surgical (ISRG) Up 5.4% Since the Last Earnings Report? - May 19 at 10:30 AM logoGoldman Sachs Group Inc Initiates Coverage on Intuitive Surgical, Inc. (ISRG) - May 16 at 8:56 PM logoGoldman just put a $1,000 price target on this red-hot surgical robot maker - May 16 at 11:00 AM logoIntuitive Surgical Reports New Employee Option Grants for May 2017 - GlobeNewswire (press release) - May 12 at 8:38 PM logoIntuitive Surgical Reports New Employee Option Grants for May 2017 - May 12 at 8:38 PM logoSumway Development Ltd. Buys Intuitive Surgical Inc, Iridium Communications Inc, Sells Tesla Inc - May 10 at 1:14 PM logo4 Stocks I’m Never Selling - May 9 at 12:20 PM logoI'm Already Up Over 200% on the Next Intuitive Surgical - May 7 at 6:24 PM logoI'm Already Up Over 200% on the Next Intuitive Surgical - May 7 at 11:43 AM logoIntuitive Surgical, Inc. (ISRG) SVP Curet Myriam Sells 3,385 Shares - May 5 at 11:59 PM logoJamie Samath Sells 48 Shares of Intuitive Surgical, Inc. (ISRG) Stock - May 5 at 8:59 PM logoThe Simple Reason Intuitive Surgical, Inc. Needn’t Worry About Competition - May 5 at 1:23 PM logoIntuitive Surgical, Inc. (ISRG) SVP Sells $2,833,955.85 in Stock - May 4 at 7:02 PM logoOne of David Gardner's Favorite Stocks of All Time -- Intuitive Surgical Inc. - May 4 at 6:09 PM logoOne of David Gardner's Favorite Stocks of All Time -- Intuitive Surgical Inc. - May 4 at 1:09 PM logoThis Catalyst Added $2.6 Billion Onto Intuitive Surgical's Valuation in April - May 4 at 11:41 AM logoThis Catalyst Added $2.6 Billion Onto Intuitive Surgical's Valuation in April - May 4 at 9:50 AM logo10 Reasons Why Intuitive Surgical is the Best Medical Device Stock - May 3 at 10:37 PM logoPositive Press Coverage Likely to Affect Intuitive Surgical (ISRG) Stock Price - May 3 at 12:50 AM logoIntuitive Surgical, Inc. (ISRG) Receives Average Recommendation of "Buy" from Analysts - May 2 at 2:26 PM logoBetter Buy: Intuitive Surgical, Inc. vs. Medtronic - May 2 at 7:19 AM logoIntuitive Surgical, Inc. (ISRG) Lowered to "Hold" at Zacks Investment Research - May 1 at 11:02 PM logoIntuitive Surgical (ISRG) Earns Coverage Optimism Score of 0.45 - April 29 at 4:46 PM logoIntuitive Surgical, Inc. (ISRG) CFO Marshall Mohr Sells 8,950 Shares - April 29 at 1:23 AM logoIntuitive Surgical, Inc. (ISRG) Upgraded to Buy at Zacks Investment Research - April 28 at 10:40 AM logoInsider Selling: Intuitive Surgical, Inc. (ISRG) VP Sells 626 Shares of Stock - April 27 at 5:52 PM logoIntuitive Surgical, Inc. (ISRG) Forecasted to Post FY2017 Earnings of $20.41 Per Share - April 27 at 1:34 PM logo$4.97 EPS Expected for Intuitive Surgical, Inc. (ISRG) This Quarter - April 27 at 9:54 AM logoIntuitive Surgical Receives CE Mark for Latest da Vinci® Robotic-Assisted Surgical System - April 26 at 7:22 PM logoFavorable Media Coverage Very Likely to Impact Intuitive Surgical (ISRG) Stock Price - April 26 at 5:24 PM logoFY2019 EPS Estimates for Intuitive Surgical, Inc. (ISRG) Lifted by Wedbush - April 26 at 5:20 PM logoIntuitive Surgical's new da Vinci X CE Mark'd - April 26 at 7:23 AM logo5 Stock Picks for April From Motley Fool Co-Founder David Gardner - April 25 at 5:27 PM logoDow Industrials Lead; Can These 4 Big Cap Stocks Smash S&P 500? - April 25 at 5:27 PM logoBrokers Set Expectations for Intuitive Surgical, Inc.'s FY2018 Earnings (ISRG) - April 25 at 2:49 PM logoIntuitive Surgical, Inc. (ISRG) Given New $785.00 Price Target at Evercore ISI - April 25 at 1:34 PM logoIntuitive Surgical, Inc. (ISRG) EVP Sells $4,052,600.00 in Stock - April 24 at 10:58 PM logoIntuitive Surgical, Inc. (ISRG) Stock Rating Reaffirmed by Wedbush - April 24 at 8:26 PM



Intuitive Surgical (ISRG) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by Staff